Spotlight Asset Group’s AbbVie ABBV Stock Holding History

Spotlight Asset Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$968K	Hold	5,641	–	–	0.68%	28
2024 Q1	$1.03M	Hold	5,641	–	–	0.74%	28
2023 Q4	$841K	Hold	5,641	–	–	0.76%	24
2023 Q3	$841K	Hold	5,641	–	–	0.76%	24
2023 Q2	$760K	Hold	5,641	–	–	0.68%	26
2023 Q1	$830K	Buy	+5,641	New	+$862K	0.83%	23
2022 Q3	$830K	Buy	+5,641	New	+$809K	0.83%	23
2021 Q3	$603K	Sell	5,592 -192	-3%	-$21.9K	0.3%	60
2021 Q2	$652K	Hold	5,784	–	–	0.25%	62
2021 Q1	$626K	Buy	5,784 +158	+3%	+$16.9K	0.24%	68
2020 Q4	$603K	Sell	5,626 -700	-11%	-$67.3K	0.22%	68
2020 Q3	$554K	Buy	6,326 +256	+4%	+$24.1K	0.22%	76
2020 Q2	$596K	Buy	6,070 +1,019	+20%	+$89.7K	0.25%	66
2020 Q1	$385K	Hold	5,051	–	–	0.2%	72
2019 Q4	$403K	Buy	+5,051	New	+$419K	0.19%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Spotlight Asset Group's ABBV Position: Q2 2024 in Review

Spotlight Asset Group held its AbbVie (ABBV) position steady in Q2 2024 at 5,641 shares worth $968K. The position accounts for 0.68% of the portfolio, ranked #28.

Spotlight Asset Group first reported a position in ABBV in Q4 2019 and has held it in 15 quarters since. The position peaked at $1.03M in Q1 2024. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Spotlight Asset Group held 5,641 shares of AbbVie worth $968K as of Q2 2024.
Spotlight Asset Group left its AbbVie share count unchanged in Q2 2024.
AbbVie made up 0.68% of Spotlight Asset Group's portfolio in Q2 2024, its #28 holding.
Spotlight Asset Group first reported a position in AbbVie in Q4 2019 and has held it in 15 quarters since.
Spotlight Asset Group's AbbVie position peaked at $1.03M in Q1 2024.
3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.